University College London (UCL) analysed records from more than 50,000
patients across Europe, including the U.K., and calculated how many
people’s cancer would have progressed from one stage owing to delays in
beginning or continuing treatment.
Both screening services and treatments were disrupted in 2020 and 2021 by lockdown restrictions, staff shortages and fear of infection.
The
team who worked with the University of Basel, in Switzerland, estimated
that around 17% of people progressed to a higher stage of cancer in
2020-2021, owing to delays in diagnosis or treatment of two to three
months or longer.
It equates to more than 12,000 years of life lost in Britain and to more than 100,000 years of life lost across Europe....<<<Read More>>>...